Kui Chan

Principal Scientist Cyrus Biotechnology Inc.

As a Principal Scientist at Cyrus Biotechnology with over 4.5 years in this role, Kui specializes in protein engineering, translational biologics R&D, and implementing AI-driven solutions to enhance research and development strategies. His expertise is rooted in creating scalable AI platforms and models that integrate multimodal datasets, enabling targeted advancements in molecular design, developability, and clinical applications.

With over 15 years of experience, Kui has contributed to therapeutic protein design, immunogenicity mitigation, and translational candidate progression, combining computational insights with experimental data. Kui is committed to embedding AI into biopharma workflows, collaborating with multidisciplinary teams to drive impactful scientific and clinical outcomes that advance patient care.

Seminars

Wednesday 30th September 2026
Building Fit-for-Purpose Datasets for AI-Driven Enzyme Engineering: Balancing Data Quality, Accessibility & Industrial Relevance
1:40 pm
  • Identify the key barriers to generating and sharing high-quality enzyme engineering datasets, including standardization, IP constraints, and experimental variability
  • Explore approaches for creating robust, industrially relevant datasets that improve model predictability, benchmarking, and decision-making
  • Discuss how organizations can leverage automation, high-throughput experimentation, and collaborative data initiatives to accelerate AI-enabled enzyme engineering
Kui Chan